{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:21:02Z","timestamp":1785464462696,"version":"3.56.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1977,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1469-0691.2009.02909.x","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T11:23:04Z","timestamp":1248348184000},"page":"613-624","source":"Crossref","is-referenced-by-count":52,"title":["Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues"],"prefix":"10.1016","volume":"15","author":[{"given":"M.C.","family":"Arendrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.T.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.02909.x_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00001622-200301000-00004","article-title":"Recent advances in pediatric acute lymphoblastic and myeloid leukemia","volume":"15","author":"Ravindranath","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)60108-7","article-title":"Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth","volume":"371","author":"lams","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib4","series-title":"Pediatric stem cell transplant Vol","first-page":"3","article-title":"The scientific basis of pediatric bone marrow transplant","author":"Mehta","year":"2004"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/clinids\/21.2.277","article-title":"Selected medically important fungi and some common synonyms and obsolete names","volume":"21","author":"McGinnis","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi-national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00148581-200810050-00003","article-title":"Treatment of invasive candidiasis in immunocompromised pediatric patients","volume":"10","author":"Fisher","year":"2008","journal-title":"Paediatr Drugs"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-4453(96)92700-0","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"33","author":"Groll","year":"1996","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib12","first-page":"33","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997","volume":"20011","author":"McNeil","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib13","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s15010-008-9357-4","article-title":"Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections","volume":"36","author":"Cornely","year":"2008","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2165\/00003495-200767130-00001","article-title":"Changing epidemiology of rare mould infections: implications for therapy","volume":"67","author":"Malani","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0195-6701(96)90137-1","article-title":"Colonization and infection associated with Malassezia and Candida species in a neonatal unit","volume":"34","author":"Shattuck","year":"1996","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.adnc.2006.01.005","article-title":"Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit","volume":"6","author":"Devlin","year":"2006","journal-title":"Adv Neonatal Care"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib21","first-page":"338","article-title":"An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers\u2019 pet dogs","volume":"12","author":"Chang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib23","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib24","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Florl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1439-0507.1993.tb00757.x","article-title":"Rapid microscopical diagnosis of deep-seated mycoses following maceration of fresh specimens and staining with optical brighteners","volume":"36","author":"Ruchel","year":"1993","journal-title":"Mycoses"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib26","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1128\/JCM.37.8.2694-2696.1999","article-title":"Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener Blankophor","volume":"37","author":"Ruchel","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib27","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/JCM.00751-06","article-title":"Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs","volume":"44","author":"Forrest","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib28","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JCM.40.6.2182-2186.2002","article-title":"Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles","volume":"40","author":"Rigby","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/JCM.01385-07","article-title":"Multicenter evaluation of the Candida albicans\/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles","volume":"46","author":"Shepard","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/JCM.00030-08","article-title":"Rapid and accurate identification of Candida albicans isolates by use of PNA FISHFlow","volume":"46","author":"Trnovsky","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib32","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3201\/eid1210.060389","article-title":"Active surveillance for candidemia, Australia","volume":"12","author":"Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib34","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib36","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.jp.7211410","article-title":"A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis","volume":"261","author":"Sarkar","year":"2006","journal-title":"J Perinatol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00365540601071859","article-title":"Diagnostics of fungal infections in the Nordic countries: we still need to improve!","volume":"39","author":"Arendrup","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1439-0507.2006.01259.x","article-title":"Clinical and experimental evaluation of a new chromogenic medium (OCCA, Oxoid) for direct identification of Candida albicans, C. tropicalis and C. krusei","volume":"49","author":"Baixench","year":"2006","journal-title":"Mycoses"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib40","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/JCM.43.3.1210-1212.2005","article-title":"CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test","volume":"43","author":"Murray","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib41","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/JCM.32.8.1923-1929.1994","article-title":"CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species","volume":"32","author":"Odds","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib42","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/JCM.01243-07","article-title":"Revised culture-based system for identification of Malassezia species","volume":"45","author":"Kaneko","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib43","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1600-0643.2007.00801.x","article-title":"Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics","volume":"115","author":"Chryssanthou","year":"2007","journal-title":"Apmis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/JCM.35.4.877-880.1997","article-title":"Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies","volume":"35","author":"Freydiere","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/JCM.44.1.138-142.2006","article-title":"Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies","volume":"44","author":"Marot-Leblond","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib46","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/JCM.42.10.4870-4872.2004","article-title":"Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories","volume":"42","author":"Freydiere","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib47","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/JCM.41.8.3861-3863.2003","article-title":"Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT","volume":"41","author":"Freydiere","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.43.1.499-501.2005","article-title":"Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata","volume":"43","author":"Willinger","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pbc.20717","article-title":"Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders","volume":"48","author":"Hovi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib50","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/528714","article-title":"Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications","volume":"46","author":"Miceli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00006454-199603000-00011","article-title":"Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis","volume":"15","author":"Rohrlich","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/INF.0b013e3180616cbb","article-title":"Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients","volume":"26","author":"Steinbach","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-0142(20010115)91:2<311::AID-CNCR1003>3.0.CO;2-3","article-title":"Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study","volume":"91","author":"Sulahian","year":"2001","journal-title":"Cancer"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib54","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","article-title":"Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients","volume":"20","author":"Herbrecht","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(03)15393-7","article-title":"Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection","volume":"363","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib56","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/JCM.43.8.3925-3931.2005","article-title":"Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity","volume":"43","author":"Mennink-Kersten","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/00365540410020488","article-title":"Disseminated Penicillium marneffei sepsis in a HIV-positive Thai woman in Denmark","volume":"36","author":"Mens","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib58","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/CVI.00479-06","article-title":"Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay","volume":"14","author":"Wheat","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib59","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib60","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/CVI.00226-08","article-title":"Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid","volume":"15","author":"Husain","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1469-0691.2007.01938.x","article-title":"Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients","volume":"14","author":"Oliveri","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","article-title":"Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species","volume":"51","author":"Sendid","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-7-103","article-title":"Comparative evaluation of (1,3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia","volume":"7","author":"Alam","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-Dglucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients","volume":"47","author":"Hachem","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1620\/tjem.209.207","article-title":"Risk factors and impact of beta-D glucan on invasive fungal infection for the living donor liver transplant recipients","volume":"209","author":"Kawagishi","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/jmm.0.47479-0","article-title":"Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever","volume":"3","author":"Ellis","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib68","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the serum (1 \u2192 3)-beta-D-glucan assay for the diagnosis of invasive fungal infections \u2013 a study based on autopsy cases from 6 years","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib69","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","article-title":"1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia","volume":"46","author":"Senn","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib70","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1439-0507.2007.01461.x","article-title":"Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats","volume":"51","author":"Khan","year":"2008","journal-title":"Mycoses"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib72","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","article-title":"Contribution of the (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections","volume":"46","author":"Persat","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib73","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2007.04.009","article-title":"Diagnostic value of DNA, (1-3)-beta-D-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus","volume":"59","author":"Ahmad","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib74","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/JCM.35.3.636-640.1997","article-title":"Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol\/L-arabinitol ratios in urine","volume":"35","author":"Christensson","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(99)80136-3","article-title":"Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol","volume":"99","author":"Walsh","year":"1995","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib76","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JCM.38.8.3039-3042.2000","article-title":"Urine D-arabinitol\/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants","volume":"38","author":"Sigmundsdottir","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib77","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01964428","article-title":"Determination of serum arabinitol levels by mass spectrometry in patients with postoperative candidiasis","volume":"12","author":"Lehtonen","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib78","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/CCM.0b013e31816f487c","article-title":"Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia","volume":"36","author":"Louie","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/jmm.0.47732-0","article-title":"Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies","volume":"5","author":"Mancini","year":"2008","journal-title":"J Med Microbiol"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2009.02909.x_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1120009X.2007.11782441","article-title":"New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples","volume":"19","author":"Mussap","year":"2007","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.jp.7210868","article-title":"Detection of fungemia by polymerase chain reaction in critically ill neonates and children","volume":"23","author":"Tirodker","year":"2003","journal-title":"J Perinatol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib82","first-page":"177","article-title":"Aspergillus antigen and PCR assays in bone marrow transplanted children","volume":"7","author":"Bialek","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib83","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1439-0507.2008.01512.x","article-title":"Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases","volume":"51","author":"Cesaro","year":"2008","journal-title":"Mycoses"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib84","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/13693780600939955","article-title":"Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients","volume":"44","author":"El-Mahallawy","year":"2006","journal-title":"Med Mycol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.122.1.42","article-title":"Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans","volume":"122","author":"Hariprasad","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib87","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2165\/00003495-200565110-00007","article-title":"Posaconazole","volume":"65","author":"Keating","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib88","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/AAC.48.9.3543-3551.2004","article-title":"Disposition of posaconazole following single-dose oral administration in healthy subjects","volume":"48","author":"Krieter","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib89","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.01034-08","article-title":"The pharmacokinetics and absorption of Posaconazole oral suspension under various gastric conditions in healthy volunteers","volume":"53","author":"Krishna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib90","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1345\/aph.1C261","article-title":"Voriconazole: a new triazole antifungal agent","volume":"37","author":"Pearson","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2009.02909.x_bib91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1469-0691.2001.tb00012.x","article-title":"Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children","volume":"7","author":"Tollemar","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib92","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/514704","article-title":"Lipid formulations of amphotericin B: clinical efficacy and toxicities","volume":"27","author":"Wong-Beringer","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.drup.2005.06.005","article-title":"Antifungal treatment in pediatric patients","volume":"8","author":"Zaoutis","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib94","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.00751-08","article-title":"Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies","volume":"53","author":"Karlsson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2009.02909.x_bib95","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkm428","article-title":"New and emerging treatments for fungal infections","volume":"61","author":"Pasqualotto","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib96","first-page":"236","article-title":"The pharmacokinetics and safety of Caspofungin in older infants and toddlers","volume":"23","author":"Neely","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib97","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.00868-08","article-title":"Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age","volume":"53","author":"Saez-Llorens","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib98","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib99","unstructured":"Agency EM. Assessment report for mycamine [online]. http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/mycamine\/H-734-en6.pdf]. Available at: http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/mycamine\/H-734-en6.pdf. (last accessed: 25 February 2009)."},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.27.3.369","article-title":"The echinocandins","volume":"27","author":"Cappelletty","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib101","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib103","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib105","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBi-Load trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib107","series-title":"45th Annual Meeting of the Infectious Disease Society of America","first-page":"78","article-title":"Prospective, multicenter study of caspofungin for treatment of documented fungal infections in pediatric patients","author":"Zaoutis","year":"2007"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib108","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib109","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2009.02909.x_bib110","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/jac\/dkm429","article-title":"Treatment of zygomycosis: current and new options","volume":"61","author":"Rogers","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib111","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.mop.0000171320.91677.55","article-title":"Neonatal cutaneous fungal infections","volume":"17","author":"Smolinski","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib112","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates","volume":"356","author":"Manzoni","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib113","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib114","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2005.03.036","article-title":"Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight","volume":"147","author":"Kaufman","year":"2005","journal-title":"zJ Pediatr"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1651-2227.2008.00687.x","article-title":"Antifungal prophylaxis for the prevention of neonatal candidiasis?","volume":"97","author":"O'Grady","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib116","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00431-008-0680-7","article-title":"Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan","volume":"167","author":"Kobayashi","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib118","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib119","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.00751-08","article-title":"A population pharmacokinetic analysis of Voriconazole plasma concentration data from pediatric studies","volume":"53","author":"Karlsson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib120","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02909.x_bib121","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2165\/00003088-200645110-00004","article-title":"Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients","volume":"45","author":"Hennig","year":"2006","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14608776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14608776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T22:48:02Z","timestamp":1590014882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14608776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":121,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1198743X14608776"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02909.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}